Peter C. Brandt
CIK 1434099 · CEO · last filed 2026-05-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$141.1K
Companies
5
Total Filings
44
Lifetime Open-Market Net
$1.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INAB | Director | 98,690 | $1.43 | $141.1K | $200.0K | 13 | 2026-05-12 |
| Opus Genetics, Inc. (RNN) Delisted | Director | 150,000 | — | — | $171.0K | 11 | 2019-06-07 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Director | 0 | — | — | $201.0K | 6 | 2015-01-30 |
| EPOCRATES INC (EPOC) Delisted | CEO | 0 | — | — | $242.4K | 7 | 2013-03-13 |
| NOVEN PHARMACEUTICALS INC (NOVN) Delisted | President and CEO | 0 | $0.09 | $0 | $492.7K | 7 | 2009-08-27 |
Recent Filings · Page 2 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-18 | INAB | Buy (P) | +105,263 | $200.0K | EDGAR |
| 2022-06-14 | INAB | Grant (A) | — | $0 | EDGAR |
| 2021-08-02 | INAB | Grant (A) | — | $0 | EDGAR |
| 2019-06-07 | Opus Genetics, Inc. (RNN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-29 | Opus Genetics, Inc. (RNN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-12 | Opus Genetics, Inc. (RNN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-10 | Opus Genetics, Inc. (RNN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-18 | Opus Genetics, Inc. (RNN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-30 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Other (J) | −25,000 | -$182.7K | EDGAR |
| 2013-06-13 | Opus Genetics, Inc. (RNN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.